These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 32451073)

  • 1. Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer.
    Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Aokage K; Saji H; Watanabe SI;
    J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1469-1480. PubMed ID: 32451073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
    Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2102-2110.e1. PubMed ID: 28947198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological characteristics of epidermal growth factor receptor-mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearance.
    Hattori A; Matsunaga T; Fukui M; Tomita H; Takamochi K; Suzuki K
    J Thorac Cardiovasc Surg; 2024 Sep; 168(3):685-696.e2. PubMed ID: 37995863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
    Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid Lung Cancer.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Ann Thorac Surg; 2016 Aug; 102(2):407-15. PubMed ID: 27177840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Impact of Very Small Ground-Glass Opacity Component in Stage IA Solid Predominant Non-small Cell Lung Cancer.
    Hattori A; Matsunaga T; Fukui M; Suzuki K; Takamochi K; Suzuki K
    Semin Thorac Cardiovasc Surg; 2024 Summer; 36(2):251-260. PubMed ID: 36180013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer.
    Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
    Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35293580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm.
    Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M
    Jpn J Clin Oncol; 2020 Oct; 50(11):1306-1312. PubMed ID: 32901276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minor (≤ 10%) Ground-Glass Opacity Component in Clinical Stage I Non-Small Cell Lung Cancer: Associations With Pathologic Characteristics and Clinical Outcomes.
    Li M; Wang J; Bao X; Wang F; Zhou F; Song N; Wan Z; Li W; Zhang L
    AJR Am J Roentgenol; 2024 Aug; 223(2):e2431283. PubMed ID: 38809121
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic impact of tumor size eliminating the ground glass opacity component: modified clinical T descriptors of the tumor, node, metastasis classification of lung cancer.
    Nakamura S; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ishiguro F; Hirakawa A; Yokoi K
    J Thorac Oncol; 2013 Dec; 8(12):1551-7. PubMed ID: 24389437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of ground-glass areas within tumours in non-small-cell lung cancer.
    Sakurai H; Goto Y; Yoh K; Takamochi K; Shukuya T; Hishida T; Tsuboi M; Yoshida K; Ohde Y; Okumura S; Taguri M; Kunitoh H
    Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38598462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of CT-defined ground-glass opacity in early-stage lung adenocarcinomas: a single-center study and meta-analysis.
    Lee JH; Choi Y; Hong H; Kim YT; Goo JM; Kim H
    Eur Radiol; 2024 Mar; 34(3):1905-1920. PubMed ID: 37650971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiological classification of multiple lung cancers and the prognostic impact based on the presence of a ground glass opacity component on thin-section computed tomography.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Lung Cancer; 2017 Nov; 113():7-13. PubMed ID: 29110852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Ann Thorac Surg; 2017 Jul; 104(1):313-320. PubMed ID: 28433219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
    Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a Ground-glass Opacity Component on c-Stage IA Lung Adenocarcinoma.
    Li M; Xi J; Sui Q; Kuroda H; Hamanaka K; Bongiolatti S; Hong G; Zhan C; Feng M; Wang Q; Tan L
    Semin Thorac Cardiovasc Surg; 2023 Winter; 35(4):783-795. PubMed ID: 35907612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma.
    Zhou J; Li Y; Zhang Y; Liu G; Tan H; Hu Y; Xiao J; Shi H
    Oncotarget; 2017 Apr; 8(14):23312-23321. PubMed ID: 28423576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Classification of Multiple Primary Lung Cancers Based on a Ground-Glass Opacity Component.
    Hattori A; Takamochi K; Oh S; Suzuki K
    Ann Thorac Surg; 2020 Feb; 109(2):420-427. PubMed ID: 31593656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy.
    Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
    Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.